Daily notes / October 19, 2026
Lynn Sebastian Purcell reported a Conexeu Sciences share purchase
Written by a model from the facts OQRO holds and checked against them, sentence by sentence of . Published . 3 min read.

The short answer
Lynn Sebastian Purcell, a Director, reported an open-market purchase of 166,666 Conexeu Sciences shares at $3.00 each, for about $500K. The transaction date was Oct 15, 2026, and the Form 4 was filed on Oct 19, 2026. After the purchase, the filing reports an indirect holding of 3,118,514 shares.
What did Lynn Sebastian Purcell report?
The SEC Form 4 identifies Lynn Sebastian Purcell as a Director and reports an open-market purchase of 166,666 Conexeu Sciences (CNXU) shares at $3.00 each. The transaction date was Oct 15, 2026, and the filing date was Oct 19, 2026, 4 days later.
The filing puts the holding after the purchase at 3,118,514 shares, an increase of about 5.6% over the estimated holding before. It states that the shares are held indirectly.
What does the Form 4 say about the transaction?
A Form 4 reports a transaction; it does not say why it was made. General background is that many companies let insiders trade only in a window that opens after results. A transaction can also follow an option exercise, a tax bill or a pre-arranged plan; the filing does not say which of these applies here.
OQRO notes a plan only when a footnote of the filing says so.
How does the purchase compare with records OQRO holds?
OQRO holds no other open-market purchases by Lynn Sebastian Purcell in the 365 days to Oct 19, 2026. OQRO does not hold enough history on this person to say whether this is a first purchase. Only 0 of this person's disclosed purchases have had 90 days since they were reported, too few for OQRO to show a result.
OQRO's insider records for Conexeu Sciences begin on Oct 19, 2026, so there is not enough history for a 12-month baseline. In the 90 days to Oct 19, 2026, 0 other open-market purchases, about $0 by 0 insiders, were filed.
What other records and coverage are listed?
FINRA short interest for CNXU on the settlement date of Sep 30, 2026 was 210,489 shares (+22.32% on the previous report), about 1 days of average volume.
Press coverage listed by Finnhub includes “Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors” (Yahoo, Oct 15, 2026). The headline is listed as published by the outlet; OQRO has not checked it and does not summarize the article.
How did the share price move around the transaction?
CNXU closed at $3.95 on Oct 15, 2026, the last session on or before the trade date. From Sep 15, 2026 to Oct 15, 2026, the close moved from $4.45 to $3.95, a change of −11.2%. From Oct 15, 2026 to Oct 19, 2026, the close moved from $3.95 to $3.29, a change of −16.7%.
What this does not tell you?
The Form 4 does not explain why the purchase was made or whether a trading window, an option exercise, a tax bill or a pre-arranged plan applied. The filing does not explain share-price moves; other news can move a price.
Comparisons use only the filings OQRO holds. The records do not provide enough history for a 12-month baseline, and too few of this person's disclosed purchases have had 90 days since reporting for OQRO to show a result. This describes public filings and is not investment advice.
Sources
A model wrote this page from the facts OQRO holds; every number, date, name and link in it was checked against those facts before publication, and a text that failed the check was not published. It describes what was filed, not why, and it is not investment advice. How OQRO treats data
Explore the data
More daily notes
- Chernett Jorey reported an Exagen share purchase on Form 4
- Robert Nelsen reported a City Therapeutics open-market purchase
- Control Empresarial reported a Talos Energy share sale on Form 4
- Harel filed a Schedule 13G reporting a 5.2% stake in Elbit Systems
- JP Sailing Capital filed a Schedule 13G on Nextcure
- Norbel Investments filed a Schedule 13G on Papa John's Pizza